Twist Bioscience Corporation (0ME)
Munich
Closed
Oct 7, 2026
Day's Range
150.9052 wk Range
22.60Overview - 0ME - Twist Bioscience Corporation
Key Statistics
Valuation
Enterprise Value
3.00B
P/E (Trailing)
‪-126.15‬
Price / Sales (TTM)
‪8.25‬
EV / EBITDA
‪-18.72‬
Profitability
Gross Margin
‪52.75%‬
Profit Margin
‪50.72%‬
Operating Margin
‪-36.18%‬
Return on Assets
‪-12.10%‬
Return on Equity
‪-16.42%‬
Ownership
Shares Outstanding
62.67M
Price stats
50-Day Avg
‪30.59‬
200-Day Avg
‪27.91‬
Market Cap - 0ME - Twist Bioscience Corporation
Peers - 0ME - Twist Bioscience Corporation
Peer Comparison
Compared with companies in Biotechnology listed on Munich.
- 0MEMunichTwist Bioscience Corporation3.10BMarket Cap+85.89%52-week change-126.15P/E (Trailing)‪50.72%‬Profit Margin
- 0QFMunichModerna Inc.67.95BMarket Cap+87.60%52-week change25.19P/E (Trailing)‪-141.42%‬Profit Margin
- 1AEAMunichargenx SE American Depositary Receipt52.86BMarket Cap+27.22%52-week change36.82P/E (Trailing)‪32.26%‬Profit Margin
- 5VAMunichVaxcyte Inc.7.58BMarket Cap+43.53%52-week change-9.06P/E (Trailing)‪0.00%‬Profit Margin
- 30JMunichIDEAYA Biosciences Inc.3.20BMarket Cap+29.48%52-week change-26.37P/E (Trailing)‪-74.75%‬Profit Margin
- 4DNMunichDenali Therapeutics Inc.2.91BMarket Cap+28.46%52-week change-6.15P/E (Trailing)‪0.00%‬Profit Margin
- 6461MunichIntech Biopharm Corporation2.66BMarket Cap-18.06%52-week change—P/E (Trailing)‪-103.17%‬Profit Margin
Profile Summary - 0ME - Twist Bioscience Corporation
About
Twist Bioscience Corporation is a synthetic biology company that develops and sells DNA-based products for research and commercial applications. Twist Bioscience Corporation’s portfolio includes synthetic genes, gene fragments, oligonucleotide pools, and antibody libraries used in therapeutic discovery, diagnostics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
